BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best strong buy growth stocks to buy now. On August 19, Bernstein analyst William Pickering maintained a Buy rating on BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) and set a price target of $95.00.
Similarly, Evercore ISI analyst Cory Kasimov also maintained a Buy rating on BioMarin Pharmaceutical Inc. on August 11, setting a price target of $110.00.
BioMarin Pharmaceutical Inc. has an analyst consensus of Strong Buy, with its median price target of $57.48 implying an upside of 70.49% from current levels.
BioMarin Pharmaceutical Inc. develops and commercializes therapies for serious and life-threatening medical conditions and rare diseases. The company’s product pipeline includes Valoctocogene roxaparvovec, Vosoritide, and BMN 307.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
This article is originally published at Insider Monkey.
